Nektar Therapeutics (United States)

236 papers and 11.9k indexed citations i.

About

In recent decades, authors affiliated with Nektar Therapeutics (United States) have published 236 papers, which have received a total of 11.9k indexed citations. Scholars at this organization have produced 100 papers in Oncology, 71 papers in Pulmonary and Respiratory Medicine and 59 papers in Immunology on the topics of Cancer Immunotherapy and Biomarkers (47 papers), CAR-T cell therapy research (40 papers) and Inhalation and Respiratory Drug Delivery (38 papers). Their work is cited by papers focused on Pulmonary and Respiratory Medicine (3.9k citations), Molecular Biology (3.3k citations) and Oncology (2.7k citations). Authors at Nektar Therapeutics (United States) collaborate with scholars in United States, United Kingdom and Germany and have published in prestigious journals including Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology. Some of Nektar Therapeutics (United States)'s most productive authors include J. Milton Harris, John S. Patton, Peter R. Byron, J. S. Patton, C. Simone Fishburn, David Lechuga‐Ballesteros, Reinhard Vehring, Sonu Singh, Willard R. Foss and Peter L. Turecek.

In The Last Decade

Fields of papers published by authors at Nektar Therapeutics (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Nektar Therapeutics (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Nektar Therapeutics (United States) at the time of their publication.

Countries citing scholars working at Nektar Therapeutics (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Nektar Therapeutics (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Nektar Therapeutics (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nektar Therapeutics (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Office of Public Health Genomics Breakdown of academic impact, for scholars at École & Observatoire des Sciences de la Terre Breakdown of academic impact, for scholars at Fondazione Andrea Cesalpino Breakdown of academic impact, for scholars at William James College Breakdown of academic impact, for scholars at Fondation Jean-Marie Lehn Breakdown of academic impact, for scholars at Metabolon (United States) Breakdown of academic impact, for scholars at National Center for Victims of Crime Breakdown of academic impact, for scholars at Foundation for Biomedical Research
Rankless by CCL
2025